Fortress Biotech, Inc. (FBIO)
(Real Time Quote from BATS)
$3.59 USD
+0.22 (6.53%)
Updated Jan 19, 2021 01:05 PM ET
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
| Zacks Rank | Definition | Annualized Return |
|---|---|---|
| 1 | Strong Buy | 24.41% |
| 2 | Buy | 17.88% |
| 3 | Hold | 9.48% |
| 4 | Sell | 5.03% |
| 5 | Strong Sell | 1.87% |
| S&P | 500 | 10.70% |
Zacks Rank Education - Learn about the Zacks Rank
Zacks Rank Home - Zacks Rank resources in one place
Zacks Premium - The only way to fully access the Zacks Rank
4-Sell of 5 4
The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.
The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.
| Value Score | A |
|---|---|
| Growth Score | A |
| Momentum Score | A |
| VGM Score | A |
Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.
As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.
Zacks Style Scores Education - Learn more about the Zacks Style Scores
F Value C Growth B Momentum D VGM
The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.
An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.
The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.
Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank
View All Zacks #1 Ranked Stocks
Zacks News
Fortress Biotech (FBIO) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Fortress Biotech (FBIO) delivered earnings and revenue surprises of 28.57% and -14.31%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
FBIOPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Will Fortress Biotech (FBIO) Report Negative Q3 Earnings? What You Should Know
by Zacks Equity Research
Fortress Biotech (FBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FBIOPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Fortress Biotech (FBIO) Enters Oversold Territory
by Zacks Equity Research
Fortress Biotech (FBIO) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
FBIOPositive Net Change
biotechs medical
Fortress Biotech Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Fortress Biotech has been struggling lately, but the selling pressure may be coming to an end soon.
FBIOPositive Net Change
biotechs
Will Fortress Biotech to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor Fortress Biotech.
FBIOPositive Net Change
biotechs
All You Need to Know About Fortress Biotech (FBIO) Rating Upgrade to Strong Buy
by Zacks Equity Research
Fortress Biotech (FBIO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
FBIOPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Sarepta (SRPT) Jumps: Stock Rises 8.3%
by Zacks Equity Research
Sarepta (SRPT) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
SRPTPositive Net Change FBIOPositive Net Change
Fortress Biotech (FBIO) in Focus: Stock Moves 6.5% Higher
by Zacks Equity Research
Fortress Biotech (FBIO) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
ALXNPositive Net Change FBIOPositive Net Change
medical
Fortress Biotech (FBIO) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Fortress Biotech (FBIO) delivered earnings and revenue surprises of 37.29% and -1.83%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
FBIOPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Will Fortress Biotech (FBIO) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Fortress Biotech (FBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FBIOPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Fortress Biotech (FBIO) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Fortress Biotech (FBIO) delivered earnings and revenue surprises of 25.37% and 30.46%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
FBIOPositive Net Change
Moving Average Crossover Alert: Fortress Biotech, Inc. (FBIO)
by Zacks Equity Research
Moving Average Crossover Alert: Fortress Biotech, Inc. (FBIO)
FBIOPositive Net Change
Fortress Biotech (FBIO) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Fortress Biotech Inc (FBIO).
FBIOPositive Net Change
Fortress Biotech (FBIO) Looks Good: Stock Adds 5% in Session
by Zacks Equity Research
Fortress Biotech, Inc. (FBIO) shares rose over 5% in the last trading session.
FBIOPositive Net Change ACIUPositive Net Change
Fortress Biotech (FBIO) Catches Eye: Stock Moves Up 8.3%
by Zacks Equity Research
Fortress Biotech, Inc. (FBIO) moved big last session, as its shares rose over 8% on the day.
ANTHPositive Net Change FBIOPositive Net Change
Fortress Biotech (FBIO) in Focus: Stock Moves 20.9% Higher
by Zacks Equity Research
Fortress Biotech, Inc. (FBIO) moved big last session, as its shares jumped almost 21% on the day.
ABUSPositive Net Change FBIOPositive Net Change